Company Valuation: Medical Net, Inc.

Data adjusted to current consolidation scope
Fiscal Period: May 2020 2021 2022 2023 2024 2025
Market Cap 1 1,980 5,558 4,108 3,555 3,329 2,852
Change - 180.76% -26.09% -13.47% -6.36% -14.31%
Enterprise Value (EV) 1 1,785 5,072 3,748 2,826 2,830 2,647
Change - 184.21% -26.11% -24.61% 0.14% -6.44%
P/E 26.6x 42.2x 10.6x 30.4x 666x -41.6x
PBR 1.99x 4.48x 2.41x 1.86x 1.75x 1.61x
PEG - 0.6x 0x -0.4x -7x 0x
Capitalization / Revenue 0.68x 1.67x 1.1x 0.79x 0.63x 0.47x
EV / Revenue 0.61x 1.52x 1x 0.63x 0.54x 0.44x
EV / EBITDA 14.3x 14.3x 7.83x 6.42x 8.04x 15.1x
EV / EBIT 16.8x 15.3x 8.33x 7.46x 9.46x 26.7x
EV / FCF 63.7x 15.4x 21.5x 7.6x 31.7x -16.5x
FCF Yield 1.57% 6.49% 4.66% 13.2% 3.15% -6.04%
Dividend per Share 2 0.75 2.5 2.5 2.5 3 3
Rate of return 0.31% 0.39% 0.54% 0.64% 0.82% 0.95%
EPS 2 9.214 15.28 43.88 12.95 0.5528 -7.62
Distribution rate 8.14% 16.4% 5.7% 19.3% 543% -39.4%
Net sales 1 2,917 3,330 3,745 4,500 5,252 6,077
EBITDA 1 125 355 479 440 352 175
EBIT 1 106 331 450 379 299 99
Net income 1 79 129 384 116 5 -68
Net Debt 1 -195 -486 -360 -729 -499 -205
Reference price 2 245.00 645.00 466.00 393.00 368.00 317.00
Nbr of stocks (in thousands) 8,081 8,618 8,816 9,045 9,045 8,998
Announcement Date 8/31/20 A 8/31/21 A 8/31/22 A 8/31/23 A 8/30/24 A 8/27/25 A
1JPY in Million2JPY
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 13.25M
15.74x0.44x9.56x2.7% 125B
12.42x1.65x8.15x0.83% 83.23B
11.84x1.38x8.37x2.87% 25.59B
20.24x2.24x11.3x1.65% 21.59B
29.76x5.44x22.82x2.36% 20.42B
6.85x1.15x5.41x-.--% 14.86B
14.96x1.41x7.19x4.69% 14.38B
14.18x1.72x8.23x0.8% 13.35B
13.35x1.02x5.68x3.41% 12.54B
Average 15.48x 1.83x 9.63x 2.14% 33.14B
Weighted average by Cap. 15.18x 1.39x 9.55x 2.07%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 3645 Stock
  4. Valuation Medical Net, Inc.
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!